ELMOD3: Potential Drug Target for Alzheimer's (G84173)

Target Name: ELMOD3

NCBI ID: G84173

ELMOD3

ELMOD3: Potential Drug Target for Alzheimer's

ELMOD3 (Long Short-Term Memory-3) is a protein that is expressed in the brain and is known to play a role in the formation and retrieval of memories. It is also a potential drug target for the treatment of various neurological disorders, including Alzheimer's disease.

ELMOD3 is a transmembrane protein that is expressed in the brain and is involved in the formation and retrieval of memories. It is a key protein in the regulation of long-term memory and is thought to play a crucial role in the process of memory formation.

Studies have shown that ELMOD3 is involved in the formation of long-term memories and that it is important for the retention of memories. For example, researchers have found that ELMOD3 is expressed in the brain and that it is involved in the formation of long-term memories.

In addition to its role in memory formation, ELMOD3 is also thought to be involved in the retrieval of memories. Studies have shown that ELMOD3 is involved in the process of memory retrieval and that it is important for the recall of memories.

As a potential drug target, ELMOD3 is being studied for its potential therapeutic uses in the treatment of various neurological disorders, including Alzheimer's disease. Studies have shown that ELMOD3 may be a promising drug target for the treatment of Alzheimer's disease, as it is thought to be involved in the development and progression of the disease.

In conclusion, ELMOD3 is a protein that is expressed in the brain and is involved in the formation and retrieval of memories. It is also a potential drug target for the treatment of Alzheimer's disease. Further research is needed to fully understand the role of ELMOD3 in the regulation of memory and to develop effective treatments for the treatment of Alzheimer's disease.

Protein Name: ELMO Domain Containing 3

Functions: Acts as a GTPase-activating protein (GAP) for ARL2 with low specific activity

The "ELMOD3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ELMOD3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets